Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
H.M.S. Al Ubeed, Deep Jyoti Bhuyan, Muhammad A. Alsherbiny, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 604-604
Open Access | Times Cited: 86
Development of Stable Nano-Sized Transfersomes as a Rectal Colloid for Enhanced Delivery of Cannabidiol
Thope Moqejwa, Thashree Marimuthu, Pierre P. D. Kondiah, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 703-703
Open Access | Times Cited: 68
The Transdermal Delivery of Therapeutic Cannabinoids
Haleh Mahmoudinoodezh, Srinivasa Reddy Telukutla, Sukhvir Kaur Bhangu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 40
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
Sara L. Macphail, Miguel A. Bedoya‐Pérez, Rhys Cohen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids
T. Srinivasa Reddy, Roby Zomer, Nitin Mantri
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1526-1538
Open Access | Times Cited: 40
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics
Mauro Alini, Ashish D. Diwan, W. Mark Erwin, et al.
JOR Spine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 28
Current Challenges and Opportunities for Improved Cannabidiol Solubility
Khondker R. Hossain, Amani Alghalayini, Stella M. Valenzuela
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14514-14514
Open Access | Times Cited: 27
Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
Lixuan Qian, Tao Zhang, Jean C. Dinh, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol
Lucia Grifoni, Elisa Landucci, Giuseppe Pieraccini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 160-160
Open Access | Times Cited: 1
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility
Inga Jurgelāne, Karīna Egle, Andra Grava, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 19
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 19
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 7
Cannabis for Medical Use: Analysis of Recent Clinical Trials in View of Current Legislation
Francesca Baratta, Irene Pignata, Lorenzo Ravetto Enri, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy
Mendhi Henna Dasram, Pavesan Naidoo, Roderick B. Walker, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1371-1371
Open Access | Times Cited: 5
Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine
Roua A. Nouh, Ahmed Kamal, Oluwaseyi Oyewole, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 241-241
Open Access | Times Cited: 5
Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats
Sarawut Lapmanee, Sakkarin Bhubhanil, Prapimpun Wongchitrat, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 514-514
Open Access | Times Cited: 5
The endocannabinoid system as a therapeutic target in neuropathic pain: a review
Jose-Manuel Quintero, Luis E. Díaz, Ismael Galve‐Roperh, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 739-755
Closed Access | Times Cited: 5
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome
Thomas J. P. Mangnus, Krishna D. Bharwani, Maaike Dirckx, et al.
Drugs (2022) Vol. 82, Iss. 5, pp. 511-531
Open Access | Times Cited: 21
Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?
Manikandan Palrasu, Lillianne H. Wright, Manish P. Patel, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 102-119
Open Access | Times Cited: 20
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Oral delivery of cannabidiol: Revealing the formulation and absorption challenges
Andrejs Šitovs, Konstantīns Logviss, Līga Lauberte, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105316-105316
Closed Access | Times Cited: 12
Cannabidiol-Loaded Solid Lipid Nanoparticles Ameliorate the Inhibition of Proinflammatory Cytokines and Free Radicals in an In Vitro Inflammation-Induced Cell Model
Khent Primo Alcantara, John Wilfred T. Malabanan, Nonthaneth Nalinratana, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4744-4744
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top